Glutathion s transferase π indicates chemotherapy resistance in breast cancer

Journal of Surgical Research

Volumn 113, Issue 1, 2003, Pages 102-108

  Su, Fengxi ^a   Hu, Xiaoqu ^a   Jia, Weijuan ^a   Gong, Chang ^a   Song, Erwei ^a   Hamar, Peter ^b,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Apoptosis; Breast cancer; Chemotherapy resistance; FAM; GSTpi; MDR

Indexed keywords

CYCLINE; DOXORUBICIN; FLUOROURACIL; GLUTATHIONE TRANSFERASE; MITOMYCIN C;

ADULT; AGED; APOPTOSIS; ARTICLE; BIOPSY; BREAST CANCER; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR VOLUME;

EID: 0043237307     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00200-2     Document Type: Article

References (37)

1. Smith I.C., Hutcheon A.W., Heys S.D. Current potential chemotherapeutic agents used for induction chemotherapy in the tratment of breast cancer. CurrPharmDes. 6:2000;327.
2. Li J., Xu L.Z., He K.L., Guo W.J., Zheng Y.H., Xia P., Chen Y. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line. Breast Cancer Res. 3:(4):2001;253.
3. Den Boer M.L., Pieters R., Kazemier K.M., Janka-Schaub G.E., Henze G., Creutzig U., Kaspers G.J., Kearns P.R., Hall A.G., Pearson A.D., Veerman A.J. Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia. BrJ Haematol. 104:(2):1999;321.
4. Reszka E., Wasowicz W. Significance of genetic polymorphisms in glutathione S- transferase multigene family and lung cancer risk. IntJ. OccupMedEnvironmenHealth. 14:2001;99.
5. Moskaluk C.A., Duray P.H., Cowan K.H., Linehan M., Merino M.J. Immunohistochemical expression of pi-class glutathione S-transferase is down-regulated in adenocarcinoma of the prostate. Cancer. 79:(8):1997;1595.
6. Perquin M., Oster T., Maul A., Froment N., Untereiner M., Bagrel D. The glutathione-related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features. JCancer ResClinOncol. 127:2001;368.
7. Mayr D., Pannekamp U., Baretton G.B., Gropp M., Meier W., Flens M.J., Scheper R., Diebold J. Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas. PatholResPrac. 196:(7):2000;469.
8. Shiga H., Heath E.I., Rasmussen A.A., Trock B., Johnston P.G., Forastiere A.A., Langmacher M., Baylor A., Lee M., Cullen K.J. Prognostic value of p53, glutathione S- transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. ClinCancer Res. 5:1999;4097.
9. Inoue T., Ishida T., Sugio K., Maehara Y., Sugimachi K. Glutathione S transferase Pi is a powerful indicator in chemotherapy of human lung squamous-cell carcinoma. Respiration. 62:1995;223.
10. Soubeyran I., Quenel N., Mauriac L., Durand M., Bonichon F., Coindre J.M. Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen a study of 74 cases . Br JCancer. 73:1996;735.
11. Konishi I., Nanbu K., Mandai M., Tsuruta Y., Kataoka N., Nagata Y., Mori T. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma. GynecolOncol. 70:1998;365.
12. Brotherick I., Shenton B.K., Egan M., Cunliffe W.E., Browell D.A., Lunt L.G., Young J.R., Higgs M.J. Examination of multidrug resistance in cell lines and primary breast tumours by flow cytometry. EurJCancer. 32A:1996;2334.
13. Gilbert L., Elwood L.J., Merino M., Masood S., Barnes R., Steinberg S.M., Lazarous D.F., Pierce L., d'Angelo T., Moscow J.A. A pilot study of pi-class glutathione S- transferase expression in breast cancer correlation with estrogen receptor expression and prognosis in node-negative breast cancer . J ClinOncol. 11:1993;49.
14. Terry J.D. Percutaneous core biopsy of the breast. Radiology. 196:1995;581.
15. Celis J.E., Celis A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells subdivision of S phase . ProcNatlAcadSciUSA. 82:1985;3262.
16. Ayhan A., Yasui W., Yokazaki H., Kitada Y., Tahara E. Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastasis in human colorectal carcinomas. Virchows ArchB CellPathol. 63:1993;213.
17. Song E., Chen J., Ouyang N., Wang M., Exton M.S., Heemann U. Kupffer cells of cirrhotic rat livers sensitize colon cancer cells to Fas-mediated apoptosis. Br JCancer. 84:2001;1265.
18. Hartung J. Lehr und Handbuch der angewandten Statistik. 1987;612, 859-900 R Oldenburg Verlag, München, Wien.
19. Mitrunen K., Jourenkova N., Kataja V., Eskelinen M., Kosma V.M., Benhamou S., Vainio H., Uusitupa M., Hirvonen A. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer EpidemiolBiomarPreven. 10:2001;229.
20. Lizard-Nacol S., Coudert B., Colosetti P., Riedinger J.M., Fargeot P., Brunet-Lecomte P. Glutathione S-transferase M1 null genotype lack of association with tumour characteristics and survival in advanced breast cancer . Breast Cancer Res. 1:1999;81.
21. Maugard C.M., Charrier J., Pitard A., Campion L., Akande O., Pleasants L., Ali-Osman F. Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifier. IntJCancer. 91:2001;334.
22. Ambrosone C.B., Coles B.F., Freudenheim J.L., Shields P.G. Glutathione-S-transferase (GSTM1) genetic polymorphisms do not affect human breast cancer risk, regardless of dietary antioxidants. J. Nutrit. 129:(2S Suppl):1999;565S.
23. Helzlsouer K.J., Selmin O., Huang H.Y., Strickland P.T., Hoffman S., Alberg A.J., Watson M., Comstock G.W., Bell D. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J NatlCancer Ins. 90:1998;512.
24. Millikan R., Pittman G., Tse C.K., Savitz D.A., Newman B., Bell D. Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer EpidemiolBiomarPreven. 9:2000;567.
25. Curran J.E., Weinstein S.R., Griffiths L.R. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility. Cancer Lett. 153:2000;113.
26. Alpert L.C., Schecter R.L., Berry D.A., Melnychuk D., Peters W.P., Caruso J.A., Townsend A.J., Batist G. Relation of glutathione S-transferase alpha and mu isoforms to response to therapy in human breast cancer. ClinCancer Res. 3:1997;661.
27. Sweeney C., McClure G.Y., Fares M.Y., Stone A., Coles B.F., Thompson P.A., Korourian S., Hutchins L.F., Kadlubar F.F., Ambrosone C.B. Association between survival after treatment for breast cancer and glutathione S-transferase P1 Ile105Val polymorphism. Cancer Res. 60:2000;5621.
28. Goto S., Iida T., Cho S., Oka M., Kohno S., Kondo T. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free RadRes. 31:1999;549.
29. Okamura T., Kurisu K., Yamamoto W., Takano H., Nishiyama M. NADPH/ quinone oxidoreductase is a priority target of glioblastoma chemotherapy. IntJOncol. 16:2000;295.
30. Nishiyama M., Yamamoto W., Park J.S., Okamoto R., Hanaoka H., Takano H., Saito N., Matsukawa M., Shirasaka T., Kurihara M. Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves. ClinCancer Res. 5:1999;2620.
31. NicAmhlaoibh R., Heenan M., Cleary I., Touhey S., O'Loughlin C., Daly C., Nunez G., Scanlon K.J., Clynes M. Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNA. IntlJCancer. 82:1999;368.
32. Nishiyama M., Suzuki K., Kumazaki T., Yamamoto W., Toge T., Okamura T., Kurisu K. Molecular targeting of mitomycin C chemotherapy. IntlJCancer. 72:1997;649.
33. Gaudiano G., Koch T.H., Lo Bello M., Nuccetelli M., Ravagnan G., Serafino A., Sinibaldi-Vallebona P. Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/DOX cells. Inhibition of glutathione S-transferase p1-1 by glutathione conjugates from anthracyclines. BiochemPharmacol. 60:2000;1915.
34. Niitsu Y., Takahashi Y., Ban N., et al. A proof of glutathione S-transferase-pi-related multidrug resistance by transfer of antisense gene to cancer cells and sense gene to bone marrow stem cell. Chemico-BiolInteractions. 111-112:1998;325.
35. Konishi I., Nanbu K., Mandai M., Tsuruta Y., Kataoka N., Nagata Y., Mori T. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma. GynecolOncol. 70:1998;365.
36. Esteller M., Corn P.G., Urena J.M., Gabrielson E., Baylin S.B., Herman J.G. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res. 58:1998;4515.
37. Jhaveri M.S., Morrow C.S. Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells. Gene. 210:1998;1.